The present study was a descriptive, non-interventional, retrospective cohort study aimed at evaluating early data on adherence, persistence, and treatment patterns among patients receiving inclisiran and other lipid-lowering therapies (LLT) in a real-world setting in Germany. Analysis was carried out using the IQVIA™ LRx database.
Study Type
OBSERVATIONAL
Enrollment
1,109
Novartis
Basel, Switzerland
Number and percentage of patients with at least 5 months of potential follow-up who were prescribed a second dose of inclisiran
Time frame: 8 months
Percentage of patients who were prescribed a second dose of inclisiran between 1 and 6 months after prescription of first dose
Time frame: 8 months
Median time between first and second prescribed doses
Time frame: 8 months
Age and gender characteristics
Time frame: 6 months
Age and gender distribution
Time frame: 6 months
Prescriber specialty distribution for patients
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.